This study is a narrative review, meaning it summarizes existing information rather than testing a new idea on people or animals. It focuses on carbapenem-resistant Escherichia coli, a specific bacteria that has become difficult to treat with certain powerful antibiotics. The authors gathered current knowledge to help guide how doctors and health officials handle these infections.
The review suggests that understanding these resistant bacteria helps improve clinical care and public health strategies. It aims to inform policies on antimicrobial resistance and supports the One Health approach, which connects human, animal, and environmental health. This broad perspective is important for stopping the spread of resistant germs across different settings.
Readers should understand that this work provides a foundation for decision-making but does not report new patient data or specific drug trials. There were no safety concerns reported because the study did not test a new medication. While the information is useful for planning, it does not replace direct medical advice or immediate changes to individual treatment plans.
